Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: A retrospective case-controlled MRI data bank analysis

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Jesse, Sarah ^a   Kassubek, Jan ^a   Müller, Hans Peter ^a   Ludolph, Albert C ^a   Unrath, Alexander ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Globus pallidus internus; Morphological changes; MRI; Parkinson's disease; Progressive supranuclear palsy; Substantia nigra

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORTICOBASAL SYNDROME; DEGENERATIVE DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; GLOBUS PALLIDUS; GLOBUS PALLIDUS INTERNUS; HEMISPHERE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTISYSTEM ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PREDICTIVE VALUE; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DATA BANK; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ATROPHY; BASAL GANGLIA; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE DEGENERATION; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SUBSTANTIA NIGRA; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84872410481     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-163     Document Type: Article

References (33)

1. Feamley JM, Lees AJ. Striatonigral degeneration: a clinicopathological study. Brain 1990, 113:1823-1842. 10.1093/brain/113.6.1823, 2276046.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184. 10.1136/jnnp.55.3.181, 1014720, 1564476.
3. Jankovic J, Rajput A, McDermott M, Perl D. The evolution of diagnosis in early Parkinson Disease. Arch Neurol 2000, 57:369-372. 10.1001/archneur.57.3.369, 10714663.
4. Caslake R, Moore JN, Gordon JC, Harris CE, Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry 2008, 79:1202-1207. 10.1136/jnnp.2008.144501, 18469029.
5. Winkler J, Ehret R, Büttner T, Dillmann U, Fogel W, Sabolek M, Winkelmann J, Kassubek J. Parkinson's disease risk score: Moving to a premotor diagnosis. J Neurol 2011, 258:311-315.
6. Isaias IU, Antonini A. Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis 2010, 7:319-329. 10.1159/000314498, 20616566.
7. Behnke S, Schröder U, Berg D. Transcranial sonography in the premotor diagnosis of Parkinson's disease. Int Rev Neurobiol 2010, 90:93-106.
8. Seppi K, Poewe W. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am 2010, 20:29-55. 10.1016/j.nic.2009.08.016, 19959017.
9. Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL. Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78:1383-1386. 10.1136/jnnp.2007.121525, 2095589, 17615165.
10. Peran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Demonet JF, Stefani A, Pierantozzi M, Pontieri F, Caltagirone C, Spalletta G, Sabatini U. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133:3423-3433. 10.1093/brain/awq212, 20736190.
11. Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009, 72:1378-1384. 10.1212/01.wnl.0000340982.01727.6e, 2677508, 19129507.
12. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004, 75:481-484. 10.1136/jnnp.2003.021873, 1738942, 14966170.
13. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004, 318:121-134. 10.1007/s00441-004-0956-9, 15338272.
14. Hughes AJ, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184. 10.1136/jnnp.55.3.181, 1014720, 1564476.
15. Hughes AJDS, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001, 57:1497-1499. 10.1212/WNL.57.8.1497, 11673599.
16. Gilman SLP, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res 1998, 8:359-362. 10.1007/BF02309628, 9869555.
17. Litvan IAY, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDSSPSP international workshop. Neurology 1996, 47:1-9. 10.1212/WNL.47.1.1, 8710059.
18. Dickson DWBC, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002, 61:935-946.
19. Scheltens P, Barkhof F, Leys D. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993, 114:7-12. 10.1016/0022-510X(93)90041-V, 8433101.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
21. Hu MT, White SJ, Herlihy AH, Chaudhuri KR, Hajnal JV, Brooks DJ. A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 2001, 56:1195-2000. 10.1212/WNL.56.9.1195, 11342685.
22. Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson Disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. Am J Neuroradiol 2002, 23:1747-1756.
23. Loizou C, Pattichis MS, Seimenis I, Pantziaris M, Pattichis CS. Multiscale amplitude-modulation frequency-modulation (AM-FM) texture analysis of multiple sclerosis in brain MRI images. IEEE Trans Inf Technol Biomed 2011, 15:119-129.
24. Rolland Y, Vérin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph AC, Bensimon G, Leigh PN. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry 2011, 82:1025-1032. 10.1136/jnnp.2010.214890, 3152869, 21386111.
25. Savoiardo M. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 2003, 24:35-37.
26. Nilsson C, Markenroth Bloch K, Brockstedt S, Lätt J, Widner H, Larsson EM. Tracking the neurodegeneration of parkinsonian disorders-a pilot study. Neuroradiology 2007, 49:111-119. 10.1007/s00234-006-0165-1, 17200869.
27. Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson's Disease. Springer (Berlin Heidelberg) 2009, ISBN 9783540798491.
28. Braak H, De Vos RA, Jansen ENH, Bratzke HJ, Braak E. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res 1998, 117:267-285.
29. Braak H, Del Tredici K, De Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211. 10.1016/S0197-4580(02)00065-9, 12498954.
30. Fearnley JM. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301. 10.1093/brain/114.5.2283, 1933245.
31. Takahashi H, Wakabayashi K. The cellular pathology of Parkinson's disease. Neuropathology 2001, 21:315-322. 10.1046/j.1440-1789.2001.00403.x, 11837539.
32. Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord 2011, 26:1633-1638. 10.1002/mds.23722, 21491489.
33. Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Schäfer A, Peters AM, Bowtell RW, Auer DP, Gowland PA, Bajaj NP. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 2012, 35:48-55. 10.1002/jmri.22752, 21987471.